Search Results - "ElHaddad, Alaa"

High risk Langerhans cell histiocytosis in children: the role of salvage in improving the outcome. A single center experience by Sedky, Mohamed Sedky M, Hamoda, Asmaa, Taha, Hala, Zaky, Iman, Hassanain, Omayma, ElHaddad, Alaa

“…In pediatric multi-system high risk organs (RO +) Langerhans cell histiocytosis (LCH), failing 1st line treatment has the highest mortality. We aim to present…”
Get full text

Pediatric pulmonary multisystem langerhans cell histiocytosis: does lung lesion severity affect the outcome? by Sedky, Mohamed, Gohar, Seham, Ahmed, Sonia, Zaky, Iman, Salama, Asmaa, Hassanein, Omayma, Maher, Eslam, ElHaddad, Alaa

“…Abstract Background The pediatric pulmonary multisystem Langerhans cell histiocytosis (PPM LCH) is associated with either low risk or high risk organ(s). The…”
Get full text

Patterns of expression of VEGFR2, PDGFRs and c-Kit in pediatric patients with high grade non-rhabdomyosarcoma soft tissue sarcoma by Mohammed, Mona M., Hafez, Hanafy A., Elnadi, Enas M., Salama, Asmaa I., Abd Elaziz, Abd Elaziz Saad, Ahmed, Gehad T., ELwakeel, Madeeha A., Kamal, Mohamed K., Kieran, Mark W., Elhaddad, Alaa M.

“…Introduction Activated vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs) and c-Kit have been shown to be…”
Get full text

Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation by Baumeister, Susanne H C, Mohan, Gopi S, Elhaddad, Alaa, Lehmann, Leslie

“…Immune effector cells (IEC) are a powerful and increasingly targeted tool, particularly for the control and eradication of malignant diseases. However, the…”
Get full text

Continuous and differential improvement in worldwide access to hematopoietic cell transplantation: activity has doubled in a decade with a notable increase in unrelated and non-identical related donors by Atsuta, Yoshiko, Baldomero, Helen, Neumann, Daniel, Sureda, Anna, DeVos, Jakob D, Iida, Minako, Karduss, Amado, Purtill, Duncan, Elhaddad, Alaa M, Bazuaye, Nosa G, Bonfim, Carmem, De la Camara, Rafael, Chaudhri, Naeem A, Ciceri, Fabio, Correa, Cinthya, Frutos, Cristobal, Galeano, Sebastian, Garderet, Laurent, Gonzalez-Ramella, Oscar, Greco, Raffaella, Hamad, Nada, Hazenberg, Mette D, Horowitz, Mary M, Kalwak, Krzysztof, Ko, Bor-Sheng, Kodera, Yoshihisa, Koh, Mickey Bc, Liu, Kaiyan, McLornan, Donal P, Moon, Joon Ho, Neven, Benedicte, Okamoto, Shinichiro, Pasquini, Marcelo C, Passweg, Jakob R, Paulson, Kristjan, Rondelli, Damiano, Ruggeri, Annalisa, Seber, Adriana, Snowden, John A, Srivastava, Alok, Szer, Jeff, Weisdorf, Daniel, Worel, Nina, Greinix, Hildegard, Saber, Wael, Aljurf, Mahmoud, Niederwieser, Dietger

“…Promoting access to and excellence in hematopoietic cell transplantation (HCT) by collecting and disseminating data on global HCT activities is one of the…”
Get full text

Global characteristics and outcomes of autologous hematopoietic stem cell transplantation for newly diagnosed multiple myeloma: A study of the worldwide network for blood and marrow transplantation (WBMT) by Garderet, Laurent, Gras, Luuk, Koster, Linda, Baaij, Laurien, Hamad, Nada, Dsouza, Anita, Estrada‐Merly, Noel, Hari, Parameswaran, Saber, Wael, Cowan, Andrew J., Iida, Minako, Okamoto, Shinichiro, Takamatsu, Hiroyuki, Mizuno, Shohei, Kawamura, Koji, Kodera, Yoshihisa, Ko, Bor‐Sheng, Liam, Christopher, Ho, Kim Wah, Goh, A. Sim, Tan, S. Keat, Elhaddad, Alaa M., Bazarbachi, Ali, Chaudhry, Qamar un Nisa, Alfar, Rozan, Bekadja, Mohamed‐Amine, Benakli, Malek, Ortiz, Cristobal Augusto Frutos, Riva, Eloisa, Galeano, Sebastian, Bass, Francisca, Mian, Hira S., McCurdy, Arleigh, Wang, Feng Rong, Meng, Ly, Neumann, Daniel, Koh, Mickey, Snowden, John A., Schönland, Stefan, McLornan, Donal P., Hayden, Patrick John, Sureda, Anna, Greinix, Hildegard T., Aljurf, Mahmoud, Atsuta, Yoshiko, Niederwieser, Dietger

“…Autologous hematopoietic cell transplantation (AHCT) is a commonly used treatment in multiple myeloma (MM). However, real‐world global demographic and outcome…”
Get full text

Integration of measurable residual disease by WT1 gene expression and flow cytometry identifies pediatric patients with high risk of relapse in acute myeloid leukemia by Ahmed, Sonia, Elsherif, Mariam, Yassin, Dina, Elsharkawy, Nahla, Mohamed, Ayman S, Yasser, Nouran, Elnashar, Amr, Hafez, Hanafy, Kolb, Edward A, Elhaddad, Alaa

“…Molecular testing plays a pivotal role in monitoring measurable residual disease (MRD) in acute myeloid leukemia (AML), aiding in the refinement of risk…”
Get full text

Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children’s Cancer Hospital Egypt by Hammad, Mahmoud, Hafez, Hanafy, Sidhom, Iman, Yassin, Dina, Salem, Sherine, Alsheshtawi, Khaled, Hamdy, Nayera, Elsharkawy, Nahla, Elhaddad, Alaa

“…Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is widely used for high-risk acute lymphoblastic leukemia (ALL) patients in their first…”
Get full text

The role of registries in hematological disorders by Baldomero, Helen, Neumann, Daniel, Hamad, Nada, Atsuta, Yoshiko, Sureda, Anna, Iida, Minako, Karduss, Amado, Elhaddad, Alaa M., Bazuaye, Nosa G., Bonfim, Carmem, Camara, Rafael de la, Chaudhri, Naeem A., Ciceri, Fabio, Correa, Cinthya, Frutos, Cristobal, Galeano, Sebastian, Garderet, Laurent, Greco, Raffaella, Jaimovich, Gregorio, Kodera, Yoshihisa, Koh, Mickey BC, Liu, Kaiyan, Ljungman, Per, McLornan, Donal P., Nair, Gayathri, Okamoto, Shinichiro, Pasquini, Marcelo C., Passweg, Jacob, Paulson, Kristjan, Ruggeri, Annalisa, Seber, Adriana, Snowden, John A., Srivastava, Alok, Worel, Nina, Saber, Wael, Rondelli, Damiano, Aljurf, Mahmoud, Niederwieser, Dietger

“…Hematopoietic cell transplantation (HCT) was developed more than 65 years ago to treat malignant blood disorders and irreversible bone marrow failures, with…”
Get full text

PB2226: HIGH RISK LANGERHANS CELL HISTIOCYTOSIS (LCH) IN CHILDREN: THE ROLE OF CLADRIBINE SALVAGE IN IMPROVING THE OUTCOME. A SINGLE CENTER EXPERIENCE by Sedky, Mohamed Sedky, Hamouda, Asmaa, Taha, Hala, Zaky, Iman, Hassanain, Omayma, Elhaddad, Alaa

Get full text

PB2222: DOES LUNG LESION SEVERITY AFFECT THE OUTCOME IN PEDIATRIC PULMONARY MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS? by Sedky, Mohamed Sedky, Gohar, Seham, Salama, Asmaa, Zaky, Iman, Hassanain, Omayma, Elhaddad, Alaa

Get full text

Plasma miRNA expression profile in pediatric pineal pure germinomas by Fakhry, Mona, Elayadi, Moatasem, Elzayat, Mariam G, Samir, Omar, Maher, Eslam, Taha, Hala, El-Beltagy, Mohamed, Refaat, Amal, Zamzam, Manal, Abdelbaki, Mohamed S, Sayed, Ahmed A, Kieran, Mark, Elhaddad, Alaa

“…Pure germinomas account for 40% of pineal tumors and are characterized by the lack of appreciable tumor markers, thus requiring a tumor biopsy for diagnosis…”
Get full text

An overview of childhood cancer care and outcomes in Egypt: a narrative review by Soliman, Ranin, Bolous, Nancy, Heneghan, Carl, Oke, Jason, Boylan, Anne-Marie, Eweida, Wael, Abouelnaga, Sherif, Elhaddad, Alaa

“…Childhood cancer is an urgent priority in Egypt, owing to a large number of children with cancer, the great need and demand for paediatric oncology services,…”
Get full text

SARS-CoV-2 genome variations and evolution patterns in Egypt: a multi-center study by Jalal, Deena, Elzayat, Mariam G., El-Shqanqery, Hend E., Diab, Aya A., Yahia, Abdelrahman, Samir, Omar, Bakry, Usama, Amer, Khaled, ElNaqeeb, Mostafa, Hassan, Wael, Talat, Hala S., Farawela, Hala M., Hamdy, Mona S., Soliman, May S., El Sissy, Maha H., Ezzelarab, Moushira H., El khateeb, Sara M., Soliman, Lamyaa H., Haddad, Sara E., Hatem, Ashraf, Ismail, Mohamed S., Hossam, Maha, Mansour, Tarek, Shalaby, Lobna, Soliman, Sonia, Hassan, Reem, Hammad, Mahmoud, Abdo, Ibrahim, Magdeldin, Sameh, ElHaddad, Alaa, Abouelnaga, Sherif, Sayed, Ahmed A.

“…A serious global public health emergency emerged late November 2019 in Wuhan City, China, by a new highly pathogenic virus, SARS-CoV-2. The virus evolution…”
Get full text

Barriers and Facilitators to Implementing Cost-Effective Evidence-Based Childhood Cancer Treatment in a Resource-Limited Setting in Egypt: A Qualitative Interview Study by Soliman, Ranin, Heneghan, Carl, Boylan, Anne-Marie, Oke, Jason, Eweida, Wael, Elhaddad, Alaa

“…Childhood cancer treatment is complex, resource-intensive, and expensive, and resource-limited settings would benefit from providing cost-effective treatment…”
Get full text

P552: MEASURABLE RESIDUAL DISEASE DETECTED BY WT1 IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN CHILDREN WITH ACUTE MYELOID LEUKEMIA by Elsherif, Mariam, Ahmed, Sonia, Yassin, Dina, Elsharkawy, Nahla, S Mohamed, Ayman, Yasser, Nouran, Hafez, Hanafy, Elhaddad, Alaa

Get full text

Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia working party of the European Society for blood and marrow transplantation (SAAWP of EBMT) by Iftikhar, Raheel, Ahmad, Parvez, de Latour, Regis, Dufour, Carlo, Risitano, Antonio, Chaudhri, Naeem, Bazarbachi, Ali, De La Fuente, Josu, Höchsmann, Britta, Osman Ahmed, Syed, Gergis, Usama, Elhaddad, Alaa, Halkes, Constantijn, Albeirouti, Bassim, Alotaibi, Sultan, Kulasekararaj, Austin, Alzahrani, Hazzaa, Ben Othman, Tarek, Cesaro, Simone, Alahmari, Ali, Rihani, Rawad, Alshemmari, Salem, Hamidieh, Amir Ali, Bekadja, Mohamed-Amine, Passweg, Jakob, Al-Khabori, Murtadha, Rasheed, Walid, Bacigalupo, Andrea, Chaudhry, Qamar-Un-Nisa, Ljungman, Per, Marsh, Judith, El Fakih, Riad, Aljurf, Mahmoud

“…Aplastic anemia is a relatively rare but potentially fatal disorder, with a reported higher incidence in developing countries in comparison to the West. There…”
Get full text

Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT) by AlDawsari, Ghuzayel, Elhaddad, Alaa, El Fakih, Riad, Ben Othman, Tarek, Ahmed, Parvez, Ghavamzadeh, Ardeshir, Bazarbachi, Ali, Dasouki, Majed J., Fathy, Gamal, Alzahrani, Hazzaa, Samra, Mohamed, Torjemane, Lamia, Satti, Tariq Mahmood, Shaheen, Marwan, Alfraih, Feras, Ayas, Mouhab, Alahmari, Ali, Alhayli, Saud, Nassar, Amr, Abboud, Miguel, Abdelfattah, Raafat, El Solh, Hassan, Hashmi, Shahrukh, Elhassan, Tusneem, Ahmed, Syed Osman, Aljurf, Mahmoud

“…Hematopoietic Stem Cell Transplantation (HSCT) is the only potentially curative treatment option for the hematologic complications that occur in patients with…”
Get full text

Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two transplant centers by Elborai, Yasser, Hafez, Hanafy, Moussa, Emad A., Hammad, Mahmoud, Hussein, Hany, Lehmann, Leslie, Elhaddad, Alaa

“…The outcome for advanced neuroblastoma has improved with combined modality therapy: induction chemotherapy, surgery, and consolidation with high‐dose…”
Get full text

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND SOLUTIONS by Mahmoud, Hossam Kamel, Fathy, Gamaleldin Mohamed, Elhaddad, Alaa, Fahmy, Omar Abdelrahman, Abdelmooti, Mohamed, Abdelfattah, Raafat, Bokhary, Mahmoud Tarek Sayed Ahmed

“…Hematopoietic stem cell transplantation (HSCT) is now an established treatment modality with definitive indications for many hematological disorders. However,…”
Get full text